NCT07146568Recruiting
Evaluating the Implementation and Effectiveness of the Pink and Pearl Campaign on Lung Cancer Screening at Christian Hospital
Source: ClinicalTrials.gov · Last updated 12 Aug 2026
Brief summary (registry, in English)
Inspired by the ongoing Pink \& Pearl Campaign, the breast radiology service of Christian Hospital in north St. Louis County will partner with Siteman Cancer Center to pilot this campaign in its mammography clinics in order to promote awareness, referral, and completion of lung cancer screening (LCS) among eligible women. This campaign leverages established infrastructure such as nurse navigation and referral to screening or primary care for further shared decision-making on cancer screening. The purpose of this study is to evaluate the effectiveness of the Pink \& Pearl Campaign in improving LCS uptake among LCS-eligible women undergoing mammography at Christian Hospital. This evaluation is grounded in the Integrated Screening Action Model that depicts individual- and environmental-level influences on the screening behavior process. Using an explanatory sequential mixed methods design, which combines both quantitative and qualitative approaches, our specific aims for this proposal are to: a) assess whether the Pink \& Pearl Campaign increases referrals and uptake/completion of LCS among LCS-eligible women undergoing screening mammography; b) determine median time-to-screening after referral to LCS; and c) evaluate individual and health system factors influencing LCS uptake and implementation outcomes of the campaign. These implementation outcomes will help identify whether the campaign was put in place successfully or not. This proposal will inform strategies for integrating cancer screening programs to improve poorly performing programs like LCS.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 5515 (estimated)
- First submitted
- 21 Aug 2025
- Start date
- 23 Feb 2026
- Primary completion date
- 28 Feb 2027
- Lead sponsor
- Washington University School of Medicine
- Diseases
- Lung cancer
- NCT number
- NCT07146568
What you commit to
- Study type: Interventional
- Planned participants: 5515
- From 23 Feb 2026 to the primary completion date, 28 Feb 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Criteria the registry did not label
- Eligibility Criteria - Interventional Study
- Undergoing screening mammography at Christian Hospital
- Between the ages of 50-80 years (inclusive)
- Eligibility Criteria - Survey and Interview Sub-Studies
- Part of the interventional study
- Reporting a 20 pack-year equivalent of either current smoking history or have quit in the past 15 years
- Can speak and understand English
- Not diagnosed with a serious health problem that will limit life expectancy (such as previous history of lung cancer, symptoms of lung cancer such as hemoptysis or unexplained weight loss of more than 6.8 kg (15 lb) in the previous year)
- Willing and able to get treatment if lung cancer is found
- Able to understand and willing to sign an IRB-approved written informed consent document
- Eligibility Criteria - Providers
- At least 20 years of age
- Involved in the breast radiology service or referred at least one patient to the Pink \& Pearl Campaign
- Able to provide verbal consent to participate in the interview
Age in the registry: 20 years to - · Sex: All · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Barnes-Jewish Christian Hospital Coordinator of this site? Confirm its status | St Louis | United States | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.